StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $45 at Needham
April 24, 2026 8:44 AM
Needham analyst Ami Fadia raised the price target on Harmony Biosciences Holdings Inc. (NASDAQ:
HRMY
) to $45.00 (from $44.00) while maintaining a Buy rating.
Categories
Analyst PT Change
